Company news
Merck Kgaa (XETR:MRK) news
Merck Kgaa news releases on 6ix. Latest, Sep 23, 2026: Bio-Techne Shareholders Approve Acquisition by Merck KGaA, Darmstadt, Germany
Press releases & updates
Bio-Techne Shareholders Approve Acquisition by Merck KGaA, Darmstadt, Germany
September 23, 2026
IVD Raw Material Market Report Now Available — Forecasts Market Growth from $21.5B (2026) to $31.1B by 2031, Profiling Merck KGaA, Thermo Fisher, Bio-Techne, Fapon Biotech, and 21 Other Key Players
September 8, 2026
The Hashgraph Group and Merck with support from PwC Germany develop solution for cocoa traceability and digital product passports
September 8, 2026
Münchener Rückversicherungs-Gesellschaft AG: Mari-Lizette Malherbe, buy
August 10, 2026
Merck Opens BioReliance® Testing Facility in Darmstadt, Germany to Support Drug Product Release in Europe
July 16, 2026
Merck : MilliporeSigma Announces BioReliance® Testing Facility Opening in Darmstadt, Germany
July 16, 2026
Merck : European Commission Approves Erbitux® (cetuximab) in Combination with Encorafenib and FOLFOX for First-Line Treatment of Metastatic Colorectal Cancer with BRAF V600E Mutation
July 14, 2026
Merck : Darmstadt, Germany, Announces FDA Breakthrough Therapy Designation for Enpatoran in Lupus Patients with Active Skin Manifestations
July 8, 2026
Merck KGaA: Merck Agrees to Acquire Bio-Techne Corporation
June 25, 2026
Merck : Darmstadt, Germany, Announces Healthcare Leadership Changes for Global Commercial Strategy and North America
June 24, 2026
Merck KGaA, Darmstadt, Germany, Collaborates with Versant Ventures to Launch Saturnus Bio to Advance Treatments for Rare Genetic Cardiomyopathies
June 23, 2026
Merck : MilliporeSigma Appoints New Heads of Discovery Solutions and Strategy & BD
June 8, 2026
Merck KGaA, Darmstadt, Germany Selects Veeva Vault CRM Worldwide
May 27, 2026
Merck KGaA, Darmstadt, Germany, Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer
May 21, 2026
Merck : Q1 26 Press Release
May 13, 2026
Merck : Darmstadt, Germany, Delivers Solid Start to the Year and Upgrades Full-Year Guidance
May 13, 2026
MilliporeSigma Becomes Sole Testing Provider for Genetix Biotherapeutics’ FDA-Approved Gene Therapies
May 7, 2026
Merck : Darmstadt, Germany, Opens €20 million Metrology and Inspection Site in France for Global Chip Industry
May 5, 2026
Merck KGaA, Darmstadt, Germany, Announces First Dose in Phase 3 Study with Enpatoran for Lupus Patients with Active Skin Manifestations
April 30, 2026
Remepy Announces Collaboration with Merck KGaA, Darmstadt Germany to Advance Hybrid Drugs Across Therapeutic Areas
April 28, 2026
MilliporeSigma Launches First Bio-Based Solvent Portfolio for High-Performance Liquid Chromatography
April 21, 2026
Pharmaceutical Testing Services Market Set to Witness Significant Growth by 2026-2033 |Merck KGaA, Boston Analytical
April 16, 2026
Sodium Benzoate Market Surges to Reach $2.85 Billion by 2036 at 5.4% CAGR with Merck KGaA, DuPont, Lanxess AG, Avantor
April 7, 2026
MilliporeSigma Completes Acquisition of JSR Life Sciences’ Chromatography Business, Expanding Protein A Capabilities and Downstream Portfolio
April 1, 2026
Merck KGaA, Darmstadt, Germany: Guidance for 2025 Delivered, Growth Foundation in Place
March 5, 2026
EMD Serono Advances Patient Access to IVF Medicines in the U.S., Aligned with National Health Priorities
February 6, 2026
Merck : Benjamin Hein Appointed as Member of the Executive Board of Merck KGaA, Darmstadt, Germany, and CEO of Electronics
January 29, 2026
Merck and ChemLex Sign Memorandum of Understanding to Advance Automated Chemistry and Technological Innovation
January 20, 2026
FDA Accepts New Drug Application for Pimicotinib for the Treatment of Tenosynovial Giant Cell Tumor
January 12, 2026
Abbisko Therapeutics’ CSF-1R Inhibitor Pimicotinib Approved by the China NMPA, Addressing the Treatment Gap for Tenosynovial Giant Cell Tumor
December 22, 2025
Valo Health Announces Collaboration with Merck KGaA, Darmstadt, Germany to Discover and Develop Novel Treatments for Parkinson’s Disease and Related Disorders
November 20, 2025
Universal Display Corporation to Acquire Emissive OLED Patent Assets from Merck KGaA, Darmstadt, Germany
November 6, 2025
Merck KGaA, Darmstadt, Germany Signs Long-Term Renewable Energy Contract for South Korea Sites
November 4, 2025
MilliporeSigma Partners with Promega to Advance 3-D Cell Drug Discovery Technologies
October 28, 2025
SpringWorks Therapeutics Announces Publication of Long-Term Efficacy and Safety Data from the Phase 3 DeFi Trial of OGSIVEO® (nirogacestat) in Adults with Desmoid Tumors in the Journal of Clinical Oncology
October 21, 2025
EMD Serono Announces Unprecedented Agreement with U.S. Government to Expand Access to IVF Therapies
October 16, 2025
MilliporeSigma to Acquire Chromatography Business of JSR Life Sciences, Expanding Protein A Capabilities and Downstream Portfolio
October 15, 2025
Biocytogen Enters into Agreement with Merck, KGaA, Darmstadt, Germany to Advance Antibody-Conjugated Lipid-Based Delivery Solutions
September 3, 2025
Merck KGaA, Darmstadt, Germany, Appoints David Weinreich as New Global Head of R&D and Chief Medical Officer for Healthcare Business Sector
September 2, 2025
Zhejiang-based GNMI Expands Overseas: Hangzhou Becomes a New Starting Point for the China-German Industrial Synergies
September 1, 2025
Skyhawk Therapeutics Announces Strategic Collaboration with Merck KGaA, Darmstadt, Germany to Discover Novel RNA-Targeting Small Molecules for Neurological Disorders
August 18, 2025
C4 Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Highlights
August 7, 2025
MilliporeSigma and Washington University in St. Louis Sign MoU to Advance Scientific Collaboration
July 24, 2025
European Commission Grants Conditional Approval of EZMEKLY® (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN
July 18, 2025
MilliporeSigma Launches AAW™ Workstation to Advance Lab Automation
July 15, 2025
Merck KGaA, Darmstadt, Germany Completes Acquisition of SpringWorks Therapeutics to Accelerate Sustainable Growth of its Healthcare Business
July 1, 2025
MilliporeSigma Announces Neoclease as Winner of 2025 North American Advance Biotech Grant
June 18, 2025
Merck KGaA, Darmstadt, Germany to Acquire SpringWorks Therapeutics to Accelerate Sustainable Growth of Healthcare Business
April 28, 2025